NASDAQ:HLVX HilleVax (HLVX) Stock Forecast, Price & News $17.94 -0.56 (-3.03%) (As of 05:40 PM ET) Add Compare Share Share Today's Range$17.32▼$18.6150-Day Range$12.93▼$18.7652-Week Range$7.90▼$24.42Volume76,005 shsAverage Volume57,042 shsMarket Capitalization$703.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media HilleVax MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish5.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.55) to ($3.12) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.76 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for HilleVax. Previous Next 0.0 Short Interest Percentage of Shares Shorted5.54% of the float of HilleVax has been sold short.Short Interest Ratio / Days to CoverHilleVax has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldHilleVax does not currently pay a dividend.Dividend GrowthHilleVax does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLVX. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for HilleVax this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for HLVX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HilleVax insiders have not sold or bought any company stock.Percentage Held by Insiders29.30% of the stock of HilleVax is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions99.11% of the stock of HilleVax is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for HilleVax are expected to grow in the coming year, from ($3.55) to ($3.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HilleVax is -4.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of HilleVax is -4.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHilleVax has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About HilleVax (NASDAQ:HLVX) StockHilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.Read More Receive HLVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HilleVax and its competitors with MarketBeat's FREE daily newsletter. Email Address HLVX Stock News HeadlinesJune 7, 2023 | finance.yahoo.comWall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should KnowJune 7, 2023 | finance.yahoo.comWall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should KnowJune 7, 2023 | MarketBeat Internal (Ad)Save $200 on MarketBeat All AccessMarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Claim your $200 account credit and free 30-day trial subscription today.May 30, 2023 | markets.businessinsider.comStifel Nicolaus Sticks to Its Buy Rating for HilleVax, Inc (HLVX)May 25, 2023 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)May 22, 2023 | finance.yahoo.comHow Much Upside is Left in HilleVax, Inc. (HLVX)? Wall Street Analysts Think 87.76%May 19, 2023 | americanbankingnews.comHilleVax (NASDAQ:HLVX) Sees Strong Trading VolumeMay 16, 2023 | msn.comJP Morgan Maintains HilleVax (HLVX) Overweight RecommendationJune 7, 2023 | MarketBeat Internal (Ad)Save $200 on MarketBeat All AccessMarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Claim your $200 account credit and free 30-day trial subscription today.May 16, 2023 | markets.businessinsider.comJ.P. Morgan Keeps Their Buy Rating on HilleVax, Inc (HLVX)May 13, 2023 | finanznachrichten.deHilleVax, Inc.: HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company ProgressMay 12, 2023 | msn.comHilleVax: Q1 Earnings InsightsMay 12, 2023 | finance.yahoo.comHilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company ProgressMay 9, 2023 | finance.yahoo.comHilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of DirectorsMay 5, 2023 | americanbankingnews.comHilleVax (HLVX) & Its Competitors Financial SurveyMay 4, 2023 | americanbankingnews.comHilleVax (HLVX) & Its Peers Financial ComparisonApril 26, 2023 | americanbankingnews.comHilleVax (HLVX) and Its Peers Financial ContrastApril 26, 2023 | americanbankingnews.comComparing HilleVax (HLVX) and Its CompetitorsApril 25, 2023 | finance.yahoo.comHilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine CandidateApril 8, 2023 | americanbankingnews.comHilleVax (HLVX) & Its Peers Head-To-Head AnalysisApril 8, 2023 | americanbankingnews.comHilleVax (HLVX) vs. Its Peers Financial AnalysisMarch 31, 2023 | americanbankingnews.comHilleVax (NASDAQ:HLVX) Stock Price Up 8.8%March 25, 2023 | americanbankingnews.comQ1 2023 Earnings Estimate for HilleVax, Inc. (NASDAQ:HLVX) Issued By SVB LeerinkMarch 22, 2023 | americanbankingnews.comHilleVax, Inc. (NASDAQ:HLVX) to Post Q1 2024 Earnings of ($0.91) Per Share, SVB Leerink ForecastsMarch 20, 2023 | finanznachrichten.deHilleVax, Inc.: HilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company ProgressMarch 17, 2023 | finance.yahoo.comHilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company ProgressJanuary 9, 2023 | finance.yahoo.comHilleVax Announces Executive Management Appointments and PromotionsSee More Headlines HLVX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLVX Company Calendar Last Earnings5/12/2023Today6/07/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HLVX CUSIPN/A CIK1888012 Webwww.hillevax.com Phone617-213-5054FaxN/AEmployees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-159,810,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-43.18% Return on Assets-37.09% Debt Debt-to-Equity Ratio0.06 Current Ratio14.00 Quick Ratio14.00 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.01 per share Price / Book2.24Miscellaneous Outstanding Shares39,200,000Free Float27,714,000Market Cap$702.86 million OptionableNot Optionable Beta0.04 Key ExecutivesDr. Robert M. Hershberg M.D. (Age 61)Ph.D., Pres, CEO & Chairman Comp: $611.2kMr. David A. Socks (Age 48)CFO & Chief Bus. Officer Comp: $561.72kMr. Aditya Kohli Ph.D. (Age 35)COO & Director Comp: $576.55kDr. Anju Chatterji Ph.D.Sr. VP of Technical OperationsMr. Paul S. Bavier J.D. (Age 51)Gen. Counsel, Sec. & Chief Admin. Officer Ms. Astrid Borkowski M.D. (Age 53)Ph.D., Chief Medical Officer Ms. Kaia AgarwalSr. VP of Regulatory AffairsMore ExecutivesKey CompetitorsAnavex Life SciencesNASDAQ:AVXLAmbrx BiopharmaNYSE:AMAMEditas MedicineNASDAQ:EDITNovavaxNASDAQ:NVAXAgenusNASDAQ:AGENView All CompetitorsInstitutional OwnershipJPMorgan Chase & Co.Bought 3,561 shares on 5/18/2023Ownership: 0.038%New York State Common Retirement FundBought 1,413 shares on 5/18/2023Ownership: 0.032%Geode Capital Management LLCBought 9,470 shares on 5/16/2023Ownership: 0.733%State Street CorpBought 12,666 shares on 5/16/2023Ownership: 0.697%Susquehanna International Group LLPBought 10,539 shares on 5/16/2023Ownership: 0.027%View All Institutional Transactions HLVX Stock - Frequently Asked Questions How have HLVX shares performed in 2023? HilleVax's stock was trading at $16.73 on January 1st, 2023. Since then, HLVX stock has increased by 7.2% and is now trading at $17.93. View the best growth stocks for 2023 here. When is HilleVax's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our HLVX earnings forecast. How were HilleVax's earnings last quarter? HilleVax, Inc. (NASDAQ:HLVX) released its quarterly earnings results on Friday, May, 12th. The company reported ($0.71) earnings per share for the quarter, beating analysts' consensus estimates of ($0.96) by $0.25. What ETFs hold HilleVax's stock? ETFs with the largest weight of HilleVax (NASDAQ:HLVX) stock in their portfolio include Direxion mRNA ETF (MSGR), ETFMG Treatments Testing and Advancements ETF (GERM), ALPS Medical Breakthroughs ETF (SBIO), Invesco Nasdaq Biotechnology ETF (IBBQ), ProShares Ultra Nasdaq Biotechnology (BIB), When did HilleVax IPO? (HLVX) raised $200 million in an initial public offering on Friday, April 29th 2022. The company issued 11,765,000 shares at $16.00-$18.00 per share. What is HilleVax's stock symbol? HilleVax trades on the NASDAQ under the ticker symbol "HLVX." Who are HilleVax's major shareholders? HilleVax's stock is owned by many different institutional and retail investors. Top institutional investors include Carlyle Group Inc. (4.69%), Franklin Resources Inc. (3.28%), BlackRock Inc. (2.65%), Geode Capital Management LLC (0.73%), State Street Corp (0.70%) and Fred Alger Management LLC (0.22%). How do I buy shares of HilleVax? Shares of HLVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is HilleVax's stock price today? One share of HLVX stock can currently be purchased for approximately $17.93. How much money does HilleVax make? HilleVax (NASDAQ:HLVX) has a market capitalization of $702.86 million. The company earns $-159,810,000.00 in net income (profit) each year or ($3.75) on an earnings per share basis. How can I contact HilleVax? The official website for the company is www.hillevax.com. The company can be reached via phone at 617-213-5054 or via email at ir@hillevax.com. This page (NASDAQ:HLVX) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.